American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$310M |
| 2 |
AbbVie
ABBV
|
+$279M |
| 3 |
L3Harris
LHX
|
+$251M |
| 4 |
VeriSign
VRSN
|
+$238M |
| 5 |
Jacobs Solutions
J
|
+$226M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$510M |
| 2 |
Texas Instruments
TXN
|
+$504M |
| 3 |
Adobe
ADBE
|
+$416M |
| 4 |
PayPal
PYPL
|
+$378M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$295M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.49% |
| 2 | Financials | 14.96% |
| 3 | Healthcare | 14.78% |
| 4 | Consumer Discretionary | 11.09% |
| 5 | Industrials | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Becton Dickinson
BDX
$50B
| $243M | 0.2% |
985,611
-53,722
| -5% | -$13.6M |
|
127
Chubb
CB
$132B
| $238M | 0.19% |
1,208,877
-993,439
| -45% | -$205M |
|
128
Healthpeak Properties
DOC
$14.2B
| $234M | 0.19% |
9,031,906
+656,611
| +8% | +$19.9M |
|
129
Duke Energy
DUK
$96.3B
| $233M | 0.19% |
2,172,707
-350,614
| -14% | -$38.6M |
|
130
Sonoco
SON
$5.74B
| $233M | 0.19% |
4,082,235
-1,468,900
| -26% | -$87.3M |
|
131
Cigna
CI
$73.3B
| $231M | 0.19% |
876,729
+320,153
| +58% | +$82.5M |
|
132
Zoetis
ZTS
$30.4B
| $226M | 0.18% |
1,313,518
-34,109
| -3% | -$5.9M |
|
133
Open Text
OTEX
$5.8B
| $225M | 0.18% |
5,945,721
-167,878
| -3% | -$6.65M |
|
134
SLB Ltd
SLB
$78.1B
| $225M | 0.18% |
6,282,207
+2,982,839
| +90% | +$124M |
|
135
Universal Health Services
UHS
$10.2B
| $225M | 0.18% |
2,230,401
+215,169
| +11% | +$26.9M |
|
136
Teleflex
TFX
$6.03B
| $224M | 0.18% |
911,383
-161,516
| -15% | -$47.1M |
|
137
DexCom
DXCM
$34.3B
| $224M | 0.18% |
3,003,159
+132,239
| +5% | +$12.1M |
|
138
ConocoPhillips
COP
$153B
| $220M | 0.18% |
2,445,627
+914,013
| +60% | +$94.2M |
|
139
Prosperity Bancshares
PB
$8.95B
| $218M | 0.18% |
3,196,327
+98,193
| +3% | +$6.74M |
|
|
140
VeriSign
VRSN
$25.6B
| $217M | 0.18% |
1,299,143
+1,296,187
| +43,849% | +$238M |
|
141
BorgWarner
BWA
$14B
| $211M | 0.17% |
7,184,756
+400,848
| +6% | +$13.2M |
|
142
Baker Hughes
BKR
$63.8B
| $210M | 0.17% |
7,289,849
-1,592,559
| -18% | -$53.8M |
|
143
US Bancorp
USB
$101B
| $210M | 0.17% |
4,569,547
+480,584
| +12% | +$24M |
|
144
First Hawaiian
FHB
$3.36B
| $209M | 0.17% |
9,204,422
+2,410,234
| +35% | +$60.5M |
|
145
Unilever
UL
$133B
| $208M | 0.17% |
4,032,136
-260,147
| -6% | -$13.2M |
|
|
146
Meta Platforms (Facebook)
META
$1.47T
| $207M | 0.17% |
1,286,187
-2,643,882
| -67% | -$510M |
|
|
BDXB
147
DELISTED
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6.00% Mandatory Convertible Preferred Stock, Series B
BDXB
| $197M | 0.16% |
3,986,466
-13,801
| -0.3% | -$708K |
|
148
Wabtec
WAB
$49.9B
| $197M | 0.16% |
2,397,066
+20,086
| +0.8% | +$1.79M |
|
149
Huntington Ingalls Industries
HII
$12.9B
| $192M | 0.16% |
881,636
+615,411
| +231% | +$130M |
|
150
Sherwin-Williams
SHW
$87.4B
| $191M | 0.16% |
854,517
-104,539
| -11% | -$26.8M |
|
Similar funds
American Century Companies's Q2 2022 Portfolio in Review
As of Q2 2022, American Century Companies held 2,437 positions worth $122B, down 16% from $146B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
American Century Companies's Q2 2022 filing shows 146 new, 1,442 increased, 596 reduced and 133 closed positions. Its largest new stake was Maravai LifeSciences: 2,396,740 shares worth $68.1M. The largest sale was Meta Platforms (Facebook), an estimated $510M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- American Century Companies's largest Q2 2022 buy was Maravai LifeSciences: 2,396,740 shares worth $68.1M.
- American Century Companies added most to NVIDIA in Q2 2022, an estimated $310M increase.
- American Century Companies's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $510M.
- American Century Companies fully exited iShares Russell Mid-Cap Value ETF in Q2 2022, selling an estimated $278M.
- American Century Companies's ten largest holdings make up 21% of its $122B portfolio in Q2 2022.
- American Century Companies opened 146 new positions and closed 133 in Q2 2022.
- American Century Companies's portfolio value fell 16% quarter-over-quarter to $122B.
Based on American Century Companies's 13F filing for Q2 2022, filed 12 Aug 2022.